• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

The Rise in the Level of Older People in the Irish Population is Expected to Contribute to Growth in the Otc Healthcare Market

Posted on: Thursday, 23 March 2006, 09:01 CST

Research and Markets (http://www.researchandmarkets.com/reports/c34707) has announced the addition of Medicated Skin Care in Ireland to their offering.

Our Medicated Skin Care in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

-- Get a detailed picture of the medicated skin care industry

-- Identify factors driving change

-- Understand the competitive environment, the market's major players and leading brands

-- Use five-year forecasts to assess how the market is predicted to develop

-- With a network of over 600 analysts worldwide, we have a unique capability to develop reliable information resources to help drive informed strategic planning.

Topics Covered

-- 1. EXECUTIVE SUMMARY

-- 2. OPERATING ENVIRONMENT

-- 2.1 OTC Healthcare Registration and Classification

-- 2.2 Vitamins and Dietary Supplements Registration and Classification

-- 2.3 Advertising

-- 2.4 Packaging and Labelling

-- 2.5 Distribution

-- 2.6 De-listing or De-reimbursement

-- 2.7 Traditional Remedies

-- 2.8 Homeopathy

-- 2.9 Generics

-- 2.10 Consumer Expenditure on Health Goods and Medical Services

-- 2.11 Life Expectancy

-- 3. OTC HEALTHCARE SALES

-- 3.1 Market Performance

-- 3.2 Switches

-- 3.3 Competitive Environment

-- 3.4 Leading Company Profiles - Crookes Healthcare Ltd

-- 3.5 Leading Company Profiles - GlaxoSmithKline (Ireland)

-- 3.6 Leading Company Profiles - Pfizer Ireland Pharmaceuticals

-- 3.7 Leading Company Profiles - Wyeth Consumer Healthcare

-- 3.8 Retail Distribution

-- 3.9 Retailer Activity and Private Label Trends

-- 3.10 Forecast Market Performance

-- 4. MEDICATED SKIN CARE SALES

-- 4.1 Sector Performance

-- 4.2 Medicated Skin Care by Herbal/Standard Split

-- 4.3 Acne Treatments Brand Shares

-- 4.4 Hair Loss Treatments Brand Shares

-- 5. OTHER OTC

-- 6. DEFINITIONS

Summary

Ageing population and rising levels of self-medication to boost forecast performance

A number of positive factors are expected to help OTC healthcare growth in Ireland. A growing number of older people in the population, an increased tendency towards self-medication, a rethink of reimbursements and longer working hours will result in rising demand for products in all OTC healthcare sectors. The entry of private label products and a larger distribution share for non specialist channels will lead to a reduction in the unit prices of some products, which could limit the pace of constant value growth overall between 2004 and 2009.

Companies Mentioned Include:

-- GlaxoSmithKline (Ireland) Ltd

-- Pfizer Ireland Pharmaceuticals

-- Crookes Healthcare Ltd

-- Reckitt Benckiser Ireland Ltd

-- Seven Seas Ireland Ltd

-- Roche Consumer Healthcare

-- SSL International Plc

-- Novartis Ireland Ltd

-- Beeline Healthcare Ltd

-- Bayer Ltd

-- Procter & Gamble (Manufacturing) Ireland Ltd

-- Unigreg Ltd

-- Stiefel Laboratories (Ireland) Ltd

-- Janssen-Cilag Ltd

-- DDD Group, The

-- Sona Healthcare Ltd

-- Johnson & Johnson (Ireland) Ltd

-- Windsor Healthcare Ltd

-- Wyeth Consumer Healthcare

-- Smith & Nephew Ltd

-- Monmouth Pharmaceuticals Ltd

-- Aventis Pharma Ltd

-- Lane Health Products Ltd, GR

-- Adams Confectionery

-- Charwell Pharmaceuticals Ltd

-- Nutricare Ltd

-- Quest Vitamins Ltd

-- Potters Ltd

-- Tosara Products Ltd

-- Vitabiotics Ltd

-- Cadbury Ireland Ltd

-- Beiersdorf Ireland Ltd

-- Ovelle Ltd

-- Quinoderm Ltd

-- Pinewood Healthcare Group

-- English Grains Ltd

-- Mentholatum Co Ltd, The

-- Masterfoods Ireland Ltd

-- Chefaro Ireland Ltd

-- Lifeplan Products Ltd

-- Antigen Pharmaceuticals Ltd

-- Ransom Consumer Healthcare

-- Hoechst Ireland Ltd

-- Fleming Medical Ltd

-- Schering-Plough (Ireland) Co

-- Clonmel Healthcare Ltd

-- 3M Ireland Ltd

-- Prestige Brands International Inc

-- Peter Black Healthcare Ltd

-- Aventis Ireland Ltd

-- Ricesteele Healthcare Ltd

-- Esi Optima Healthcare

-- Rowa Pharmaceuticals

-- Lab Ltd

-- Abbott Laboratories (Ireland) Ltd

-- Pharmacia Ireland Ltd

For more information visit http://www.researchandmarkets.com/reports/c34707

Source: Business Wire

More News in this Category